Article
Gut Microbiome and Plasma Metabolomic Analysis in Patients with Myelodysplastic Syndrome
1 Jan 2022
Abstract excerpt
Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematopoietic stem cell disorders. Studies have shown the involvement of an abnormal immune system in MDS pathogenesis. The gut microbiota are known to influence host immunity and metabolism, thereby contributing to the development of hematopoietic diseases. In this study, we performed gut microbiome and plasma metabolomic analyses in patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
